Cortexyme, inc.


Cortexyme is developing treatments for Alzheimer's and other degenerative disorders.

Information about Cortexyme, inc.

Industry
biotechnology
Number of employees
11-50
Address
269 E Grand Ave, South San Francisco, California 94080, US


Company Categories

Education), Organizations), Biotechnology), Alzheimers), Science and Engineering), Neuroscience), Medical), Neurodegenerative Disease), Health Care), Pharmaceutical),

Cortexyme, inc. executive employees

danielle elfgre

CMC Program Manager

craig hook

Director of Analytical

brendan hannah

Chief Business Officer

ted monohon

Chief Accounting Officer-VP

stewart low

Chief Scientific Officer

stephen dominy

Chief Scientific Officer

kevin wall

Senior Director Technical

craig mallinckr

Vice President

christine swei

Sr. Manager Clinical

caralee schaefe

Executive Director Preclinical

stacy roughan

Vice President Corporate

merrill biel

Executive Medical Director

mackenzie lahar

Senior Manager Corporate

leslie holsinge

Executive Vice President

jianhong wang

Executive Director Head

jeff ogi

Director of Information

debbie caporusc

Sr. Project Manager

Frequent questions about Cortexyme, inc.

How many employees does Cortexyme, inc. have?
Cortexyme, inc. has approximately 11-50 employees.
What is Cortexyme, inc.'s industry?
Cortexyme, inc. is involved in the industry of biotechnology.
Where is Cortexyme, inc. headquarters located?
Cortexyme, inc. is located in 269 E Grand Ave, South San Francisco, California 94080, US
What is the website of Cortexyme, inc.?
Cortexyme, inc. official website at cortexyme.com

Other companies



Kendo does not guarantee or claim any of the information found on this public directory to be 100% accurate or up to date.Information found here is gathered from a variety of online and offline sources.

If you wish to exclude your personal data from this public directory send us an email to [email protected]